Pregnancy With Insomnia: a Trial of Acupuncture

NCT ID: NCT03194191

Last Updated: 2017-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-30

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.

GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Scientific justification:

\- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.

Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.

* To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
* Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.

Population:

The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.

Objectives:

* Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
* Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .

Study design:

* Study Type: Multicentre, Interventional, randomized, 2 parallel groups
* Endpoint Classification: Efficacy Study
* Intervention Model: Parallel Assignment
* Masking: Single blind (patient blinded to intervention)
* Primary Purpose: Treatment
* One acupuncture session weekly for 4 consecutive weeks

Visits:

* Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
* Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
* Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
* End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insomnia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial with regular acupuncture needles vs. sham needles. In addition, the sham needles will be placed in areas that do not correspond to any known acupuncture point.

5 bilateral acupoints or placebo acupoints,
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Single blind (patient blinded to intervention)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Regular acupuncture needles

Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.

Group Type EXPERIMENTAL

Acupuncture needles

Intervention Type DEVICE

The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

Sham acupuncture needles

Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints

Group Type SHAM_COMPARATOR

Acupuncture needles

Intervention Type DEVICE

The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acupuncture needles

The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years
* Singleton pregnancy
* Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
* Insomnia Severity Index ≥ 10
* Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
* Patient understanding the study
* Informed consent signed
* Social insurance available at inclusion and until the end of pregnancy

Exclusion Criteria

* Threatened premature labor
* Small fetus for gestational age
* Pre-eclampsia
* Insomnia starting before pregnancy
* Use of psychotropic drugs before pregnancy
* Use of recreational drugs during pregnancy
* Known psychiatric disorder
* Anticoagulant therapy
* Patient reporting insomnia results from chronic or acute pain
* Obstructive sleep apnea (OSA) requiring treatment
* Patient under antidepressant therapy
* Patient under legal guardianship or deprived of freedom
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stéphanie Nicolian, Midewife

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stéphanie Nicolian, Midewife

Role: CONTACT

0033 6 25 71 08 64

Marc Dommergues, PUPH

Role: CONTACT

0033 6 08 48 69 25

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P150951

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.